Eurofins Scientific SE

ERF

FR0014000MR3

Healthcare Facilities & Services

Market Closed - Euronext Paris Other stock markets 11:35:25 2024-05-17 EDT			Pre-market 02:12:32
58.26 ^EUR	-1.65%		58.32	+0.10%

05-13	Eurofins Scientific to Expand US Battery Materials Testing Capabilities	MT
05-13	Eurofins Scientific expands capacity in the USA	CF

Eurofins Scientific SE's Equity Buyback announced on October 3, 2022, has expired.

April 23, 2024

The company expired is plan on April 24, 2024.

Latest news about Eurofins Scientific SE

Eurofins Scientific to Expand US Battery Materials Testing Capabilities	05-13	MT
Eurofins Scientific expands capacity in the USA	05-13	CF
Corella Resources Confirms High Purity Alumina Production	05-08	MT
CAC40: France's rating maintained = non-event	04-29	CF
CAC40: starts the week slightly up, crosses the 8100 mark	04-29	CF
CAC40: interest rates soar, pulling back below 8100 pts	04-24	CF
EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed	04-24
CAC40: reverses course under pressure from rates at their zenith	04-24	CF
CAC40: rise to 8.150, but interest-rate tensions hinder progress	04-24	CF
Transcript : Eurofins Scientific SE, Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024	04-24
CAC40: close to equilibrium despite Kering's plunge	04-24	CF
Eurofins: organic growth close to 7% in Q1	04-24	CF
Eurofins Scientific SE's Equity Buyback announced on October 3, 2022, has expired.	04-23	CI
CAC40: up sharply, back over 8100 pts	04-23	CF
CAC40: week ends at half-mast, gold at its zenith	04-05	CF
CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233	04-05	CF
CAC40: easily preserves 8,000Pts, NFP has no impact	04-05	CF
CAC40: ends the day balanced after a salvo of statistics	04-04	CF
CAC40: frozen at 8,155, W-Street well disposed, gold at its zenith	04-04	CF
CAC40: indecisive towards 8,160, W-Street climbs back to the top	04-04	CF
EUROFINS SCIENTIFIC : Berenberg raises its price target	04-04	CF
CAC40: up slightly after PMI figures	04-04	CF
Eurofins Scientific to Purchase US-based Ascend Clinical	04-03	MT
Eurofins completes acquisition of Ascend Clinical	04-03	CF
Eurofins Scientific SE acquired Ascend Clinical, LLC.	04-02	CI

Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).

Sector

Healthcare Facilities & Services

Calendar

2024-07-24 - Q2 2024 Earnings Release

Related indices

CAC 40 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

EUROFINS SCIENTIFIC : Q1 sees a lacklustre start to the year; 2024 outlook confirmed

April 24, 2024 at 11:50 am

More Strategies

Ratings for Eurofins Scientific SE

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

58.26 EUR

Average target price

60.88 EUR

Spread / Average Target

+4.49%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
EUROFINS SCIENTIFIC SE	-1.22%	12.22B
HCA HEALTHCARE, INC.	+19.28%	84.56B
CVS HEALTH CORPORATION	-26.95%	72.41B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.58%	27.73B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.35%	17.75B
FRESENIUS SE & CO. KGAA	-0.46%	17.11B
QUEST DIAGNOSTICS INCORPORATED	+4.69%	16.03B
REDE D'OR SÃO LUIZ S.A.	+8.14%	13.72B
NATERA, INC.	+69.96%	13.07B
FRESENIUS MEDICAL CARE AG	+6.59%	12.91B

Other Healthcare Facilities & Services